Forward P/S Multiple: BioSig Technologies, Inc. (BSGM)

Biosig Technologies - graphic logo of issuer BSGM

Biosig Technologies (BSGM) attracts top engineers with unique IT challenges and stock options. The projected market cap-to-revenue ratio on the GURU.Markets service chart visualizes this potential, where 18672.60 captures the current value of the indicator. However, trade barriers are increasing the production costs of systems, and a lack of pricing power due to government procurement pressure is forcing the company to lower the cost of its products.

BioSig Technologies - BSGM Market Cap to Projected Revenue (period 07/04/2022 - 09/12/2025)

Summary analytical data breakdowns for BioSig Technologies, Inc (BSGM)

- market price and analyst price targets:
Price Chart BioSig Technologies Inc.|BSGM - Consensus Target
- company stock exchange capitalization indicators:
Market Capitalization BioSig Technologies, Inc|BSGM - Total Enterprise Value
- issuer book value statistics:
Book Value per Share BioSig Technologies|BSGM - Accounting Capitalization|Market Capitalization to Book Value Ratio biosig.com|BSGM - Company Total Asset Base
- debt and liquidity data:
Total Debt to Capital Biosig Technologies|BSGM - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Biosig Technologies|BSGM - Company Aggregate Debts|Debt to Book Capitalization Ratio BioSig Technologies, Inc|BSGM - Company Long-Term Debt|Company Current Liabilities BioSig Technologies|Quick Ratio biosig.com
- financial results and valuation multiples details:
BSGM - Company Net Income|Expected Profit Biosig Technologies|BSGM - Market Cap to Net Income Ratio|Projected Price to Earnings BioSig Technologies, Inc.|BSGM - PEG Multiple|EV/EBITDA Multiple BioSig Technologies, Inc|BSGM - Operating income before deduction of amortization|Earnings per share for the last twelve months BioSig Technologies|BSGM - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months biosig.com|BSGM - Net earnings per share growth this year|Earnings growth forecast for next year Biosig Technologies
- sales and revenue indicators:
BSGM - Company Total Revenue|Company Projected Revenue BioSig Technologies, Inc|BSGM - Market Cap to Revenue Ratio|Forward Price-to-Revenue Multiple BioSig Technologies, Inc
Fundamental company analysis:BSGM (BioSig Technologies)
Product sample of BioSig Technologies, Inc

The implementation of robotic assembly lines and AI automation within the electrophysiology segment of Biosig Technologies (BSGM) directly impacts future revenue scalability. By analyzing the company's forward P/S ratio, an investor assesses market capitalization relative to expected sales volume, which determines the extent of the premium paid for technological potential and evaluates the sustainability of the current business valuation trend within a portfolio.

Who Biosig Technologies competes with

Price-to-Projected Revenue Ratio Dexcom DXCM|PEN - Forward Price-to-Revenue Multiple|Novanta Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Haemonetics Company|INSP: Forward P/S Multiple|Market Cap to Projected Revenue PRCT|CNMD (CONMED) - Forward P/S Multiple|Pulse Biosciences Inc (PLSE) - Market Cap to Expected Sales Ratio|Forward P/S Multiple INMD|Forward Price-to-Revenue Multiple Picard Group PMI|Forward P/S Multiple SRDX (Surmodics, Inc.)|Forward P/S Multiple senseonics.com SENS|NPCE - Price-to-Projected Revenue Ratio|TCMD: Price-to-Projected Revenue Ratio|SNWV (SANUWAVE Health, Inc.) - Forward Price-to-Revenue Multiple|Outset Medical Corp - Forward Price to Sales|ELMD (SmartVest) - Forward P/S Multiple|Market Cap to Future Revenue Ratio lensar.com LNSR|Price-to-Projected Revenue Ratio AVITA Medical (RCEL)|profoundmedical.com (PROF) - Projected Price to Revenue|Baird Medical - Forward Price-to-Revenue Multiple|Forward P/S Multiple EDAP TMS SA EDAP|Bovie Medical - Forward P/S Multiple|Market Cap to Expected Sales Ratio IceCure Medical Ltd ICCM|pulmonx.com (LUNG) - Price-to-Projected Revenue Ratio|Future Price to Revenue TELA (TELA Bio)|Price-to-Projected Revenue Ratio CytoSorbents Corp|Forward Price-to-Revenue Multiple Sensus (SRTS)|Forward P/S Multiple ZYXI|ECOR - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Vicarious Surgical RBOT|IINN: Market Cap to Projected Revenue|ICU: Forward Price-to-Revenue Multiple|IRIDEX Corporation - Price to Expected Revenue Ratio|INBS: Forward P/S Multiple|XAIR (Beyond Air) - Price-to-Projected Revenue Ratio|PFSA (Profusa) - Forward P/S Multiple|STRATA Skin (SSKN) - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio GlucoTrack (GCTK)|NAOV - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Venus Concept Inc. VERO|Market Cap to Expected Sales Ratio nuwellis.com (NUWE)|Aethlon Medical, Inc. - Forward P/S Multiple|Market Cap to Expected Sales Ratio Asensus Surgical, Inc. ASXC|AVGR: Forward P/S Multiple|Projected Price to Revenue Cutera Inc CUTR|Forward Price-to-Revenue Multiple KNW|NARI: Forward Price to Sales|Forward Price-to-Revenue Multiple NVRO (Nevro)|Price to Expected Revenue Ratio RSLS|Forward P/S Multiple SILK (Silk Road Medical Inc.)